CClinicalTrials.gg
CompletedNCT05239234Updated Nov 28, 2022

Ultrasonographic Predictors of Hypotension After Induction

An observational study in General Anesthesia and Hypotension on Induction, sponsored by Antalya Training and Research Hospital. Completed at 1 site in Turkey. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2022-11-28.

Sponsored by Antalya Training and Research Hospital · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 75 Years
Sex
All
01

Study summary

The purpose of the study is to evaluate the predictive value of the inferior vena cava collapsibility index and caval aorta index for detecting hypotension after induction of general anesthesia.

Read the detailed description

Since cardiovascular depressant and vasodilatory effects of anesthetic agents, patients may be at risk of hypotension after induction of general anesthesia. Previous studies reported that, for evaluating volume status, some ultrasonographic measurements such as inferior vena cava collapsibility index (IVCCI) could be used. Also some studies stated that measurement of aorta diameter index (IVC : Ao index) is reliable to predict hypotension after induction of spinal anesthesia. At the study, the investigators aimed to investigate the predictive values of the inferior vena cava collapsibility index and caval aorta index under ultrasound guidance in predicting post-induction hypotension in patients under general anesthesia.

02

Conditions studied

  • General Anesthesia
  • Hypotension on Induction

Browse trials for

03

In context

Hypotension

1,003 studies on the registry are indexed under Hypotension; 173 are open to participants now.

This study's enrollment of 100 is above the median of 84 across 294 observational studies indexed under Hypotension.

Browse Hypotension studies →

Lead sponsor

Antalya Training and Research Hospital is the lead sponsor of 102 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

patients who scheduled for elective non-cardiac surgery under general anesthesia

Inclusion criteria

  • patients more than 18 years of age
  • American Society of Anesthesiologists' (ASA) physical status 1 or 2

Exclusion criteria

Exclusion Criteria:

  • BMI more than 30 kg/m²
  • Use of angiotensin converting enzyme inhibitors
  • pregnancy,
  • emergency operations
  • baseline arterial systolic blood pressure less than 90 mmHg
  • mean arterial blood pressure less than 70 mmHg
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Interventions

  • OtherInferior vena cava-Aorta diameter index

    Before the induction of general anesthesia, inferior vena cava-Aorta diameter index and inferior vena cava collapsibility index will be measured.

    Also known as: Inferior vena cava collapsibility index

06

What researchers measure

Primary outcomes

  1. Diagnostic value of IVCCI to detect post-induction hypotension assessed by Receiver operating characteristic (ROC) curve analysis.

    Measurement of inferior vena cava collapsibility index.

    Time frame: 20 minutes

  2. Diagnostic value of IVC : Ao index to detect post-induction hypotension assessed by ROC curve analysis.

    Measurement of inferior vena cava-Aorta diameter index.

    Time frame: 20 minutes

07

Study locations

1 site
  • Antalya Training and Researching Hospital
    Antalya, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 28, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05239234
Lead sponsor
Antalya Training and Research Hospital
Responsible party
Sponsor
First posted
Feb 14, 2022
Start date
Mar 2, 2022
Primary completion
Nov 9, 2022
Completion
Nov 12, 2022
Last update
Nov 28, 2022

Study contacts

Enes Eskin, M.D.
principal investigator · Antalya Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion